CVRdatabase
Menu

Tetra Pharm Technologies ApS

Private limited companyCVR 40738223København SActive

Tetra Pharm Technologies ApS is a private limited company, based in København S, active in manufacture of pharmaceutical preparations, founded in 2019. Equity was negative at the end of 2025 (−DKK 25.8m). The company made a loss in both 2024 and 2025, most recently DKK 52.6m. Operations are spread over 3 production units in 3 towns.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 17.7m−1,309.7% vs. 2024
Net profit−DKK 52.6m+4.8% vs. 2024
Equity−DKK 25.8m−196.6% vs. 2024
Employees39latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 1,310% (2024 → 2025), to −DKK 17.7m.
  • The loss got smaller: from DKK 55.2m to DKK 52.6m (2024 → 2025).
  • Equity turned negative: −DKK 25.8m (2024 → 2025).

Employees

  • 9 fewer employees than a year earlier: 39 (07/2026) against 48 (07/2025).

Management and owners, last 24 months

  • New in management: Claus Berner Nielsen (board member, 01/05/2026), Jesper Breum (board member, 01/05/2026) and Søren Maarssø (chair of the board, 01/05/2026) (+4).
  • Stepped down: Martin Stefan Rose (director, 06/10/2026), Jesper Breum (director, 06/10/2026) and Jesper Breum (board member, 31/03/2025) (+5).
  • New owners registered: Breum Holding EST. 2016 ApS (10/10/2025), BrainFrame ApS (10/10/2025) and Rump Invest ApS (01/05/2026) (+2).
  • No longer registered as owner: Breum Holding EST. 2016 ApS (09/10/2025), BrainFrame ApS (09/10/2025) and Rump Invest ApS (30/04/2026) (+2).

Registrations, last 24 months

  • 01/05/2026: Share capital changed from 67,595 DKK to 75,178 DKK
  • 06/09/2025: Moved to Ørestads Boulevard 108, 2300 København S

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 60m−DKK 40m−DKK 20mDKK 0DKK 20mDKK 40mDKK 60mDKK 80m202020212022202320242025
EquityNet profit
Financial figures for Tetra Pharm Technologies ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−9263,208−5105851,461−17,669−1,309.7%
Operating profit (EBIT)−1,145−414−10,933−38,817−61,006−55,442+9.1%
Profit before tax−1,151−502−10,992−38,401−60,866−58,090+4.6%
Net profit−898306−7,768−32,947−55,214−52,590+4.8%
Total assets91218,28885,33234,58031,27822,570−27.8%
Equity−85613,78779,92432,08826,745−25,844−196.6%
Liabilities1,7683,8053,620––48,414–
Cash and cash equivalents–5,19860,9168,9283,8765,423+39.9%
Average number of employees3615243747+27%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 20m−DKK 15m−DKK 10m−DKK 5mDKK 0DKK 5m202020212022202320242025
Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 25.8m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 4 years in a row

    Net result has been negative in 2022–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Tetra Pharm Technologies ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202515/07/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202408/07/2025The companyPDFXBRL
202301/01/2023 – 31/12/202308/07/2024The companyPDFXBRL
202201/01/2022 – 31/12/202201/08/2023The companyPDF not statedXBRL
202101/01/2021 – 31/12/202122/09/2022The companyPDF not statedXBRL
202026/08/2019 – 31/12/202001/08/2021The companyPDF not statedXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0102030405008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profit−DKK 17.7mNo. 51 of 57
Better than 11% of the companies in the industry
Equity−DKK 25.8mNo. 54 of 59
Better than 9% of the companies in the industry
Number of employees39No. 19 of 59
Better than 69% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bn
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 9,860of 9,892
Better than 0%
No. 9,859of 9,922
Better than 1%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,542of 33,588
Better than 0%
No. 33,555of 33,687
Better than 0%
All companies of type ApS66,508 companies in the comparison
No. 66,329of 66,379
Better than 0%
No. 66,368of 66,505
Better than 0%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. Tetra Pharm Technologies ApS−DKK 17.7m
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. Tetra Pharm Technologies ApS−DKK 52.6m
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. Tetra Pharm Technologies ApS−DKK 25.8m
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. Tetra Pharm Technologies ApS39
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Leafy Tunnel Fund 1, L.P.5%
  • Ole GS Holding ApS5%
  • Breum Holding EST. 2016 ApS20%
  • BrainFrame ApS20%
  • Rump Invest ApS5%
  • Nesroht Holding ApS25%
Tetra Pharm Technologies ApS

Management

6 active registrations

Executive management

Executive management at Tetra Pharm Technologies ApS
NameRoleAppointed
Ulrich Wulff Norden VengeDirector06/10/2026
Rolf Sass SørensenDirector06/10/2026

Board of directors

Board of directors at Tetra Pharm Technologies ApS
NameRoleAppointed
Claus Berner NielsenBoard member01/05/2026
Jesper BreumBoard member01/05/2026
Søren MaarssøChair of the board01/05/2026
Rolf Sass SørensenBoard member01/07/2026
Founders
BrainFrame ApS
Former management (9)
Former management at Tetra Pharm Technologies ApS
NameRoleAppointedResigned
Martin Stefan RoseDirector26/08/201906/10/2026
Jesper BreumDirector01/12/202006/10/2026
Per Mogens BuggeBoard member03/09/202122/04/2024
Jesper BreumBoard member03/09/202131/03/2025
Martin Stefan RoseBoard member03/09/202101/05/2026
Søren RoseChair of the board03/09/202123/05/2025
Nikolay TretiyakovBoard member03/09/202128/03/2025
Lars Frøvang ThomsenBoard member22/04/202401/05/2026
Jesper BreumChair of the board01/04/202530/04/2026

Signing rule: Selskabet tegnes af en direktør sammen med bestyrelsesformanden eller af den samlede bestyrelse i forening

Address and production units

3 active production units

Ørestads Boulevard 108
2300 København S

København Municipality · Postcode 2300

Other companies at the address (2)

Production units
Production unitAddressEmployeesP number
Tetra Pharm Technologies ApSRugmarken 10, 3650 Ølstykke21028483763
Tetra Pharm Technologies ApSØrestads Boulevard 108, 2300 København S11024972522
Tetra Pharm Technologies ApSSøndre Jernbanevej 11, 3400 Hillerød–1031642953

Purpose

Selskabets formål er at være biotekselskab, investering samt enhver beslægtet virksomhed efter ledelsens beslutning.

The purpose is quoted from the register in Danish.

Changes year by year

58 registered events
202617 changesmanagement 11 · accounts 1 · capital 1 · ownership 4
  • Ulrich Wulff Norden Venge appointed director
  • Rolf Sass Sørensen appointed director
  • Jesper Breum stepped down as director
  • Martin Stefan Rose stepped down as director
  • Annual report for 2025 published
  • Rolf Sass Sørensen appointed board member
  • Share capital changed from 67,595 DKK to 75,178 DKK
  • Søren Maarssø appointed chair of the board
  • Jesper Breum appointed board member
  • Claus Berner Nielsen appointed board member
  • Lars Frøvang Thomsen stepped down as board member
  • Martin Stefan Rose stepped down as board member
  • RUMP INVEST ApS registered as owner (5%)
  • Nesroht Holding ApS registered as owner (25%)
  • Jesper Breum stepped down as chair of the board
  • Nesroht Holding ApS is no longer registered as owner
  • RUMP INVEST ApS is no longer registered as owner
202512 changesownership 6 · address 1 · accounts 1 · management 4
  • Nesroht Holding ApS registered as owner (20%)
  • BrainFrame ApS registered as owner (20%)
  • Breum Holding EST. 2016 ApS registered as owner (20%)
  • Nesroht Holding ApS is no longer registered as owner
  • Breum Holding EST. 2016 ApS is no longer registered as owner
  • BrainFrame ApS is no longer registered as owner
  • Moved to Ørestads Boulevard 108, 2300 København S
  • Annual report for 2024 published
  • Søren Rose stepped down as chair of the board
  • Jesper Breum appointed chair of the board
  • Jesper Breum stepped down as board member
  • Nikolay Tretiyakov stepped down as board member
20244 changesaccounts 1 · management 2 · capital 1
  • Annual report for 2023 published
  • Lars Frøvang Thomsen appointed board member
  • Per Mogens Bugge stepped down as board member
  • Share capital changed from 62,395 DKK to 67,595 DKK
20231 changeaccounts 1
  • Annual report for 2022 published
20228 changescapital 3 · ownership 4 · accounts 1
  • Share capital changed from 50,640 DKK to 62,395 DKK
  • Nesroht Holding ApS registered as owner (10%)
  • RUMP INVEST ApS registered as owner (5%)
  • Annual report for 2021 published
  • Share capital changed from 48,973 DKK to 50,640 DKK
  • OLE GS HOLDING ApS registered as owner (5%)
  • Share capital changed from 48,076 DKK to 48,973 DKK
  • Leafy Tunnel Fund 1, L.P. registered as owner (5%)
202110 changescapital 2 · ownership 2 · management 5 · accounts 1
  • Share capital changed from 46,000 DKK to 48,076 DKK
  • BWC Group Inc. is no longer registered as owner
  • Share capital changed from 40,000 DKK to 46,000 DKK
  • Martin Stefan Rose appointed board member
  • Nikolay Tretiyakov appointed board member
  • Søren Rose appointed chair of the board
  • Jesper Breum appointed board member
  • Per Mogens Bugge appointed board member
  • BWC Group Inc. registered as owner (10%)
  • Annual report for 2020 published
20202 changesmanagement 1 · address 1
  • Jesper Breum appointed director
  • Moved to Søndre Jernbanevej 11, 3400 Hillerød
20194 changesfounded 1 · management 1 · ownership 2
  • Registered as Tetra Pharm Technologies ApS
  • Martin Stefan Rose appointed director
  • Breum Holding EST. 2016 ApS registered as owner (25%)
  • BrainFrame ApS registered as owner (25%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction